Articles tagged with Nicotinamides
A UCalgary study found that adding high doses of vitamin B3 to the treatment plan may help rejuvenate compromised immune cells to kill tumour cells. The clinical trial showed promising results, with 82% of participants free of cancer progression at six-months.
A clinical trial found that nicotinamide riboside supplementation improved fatigue, sleep, and depressive symptoms in some people with long COVID. However, the overall results did not show significant differences between groups, suggesting that individual responses may vary.
Researchers highlight NAD+ supplements as potential key to healthier ageing and disease prevention, but call for larger studies. Early trials report improvements in memory, movement, and metabolism.
A new study published in JAMA Dermatology found that nicotinamide reduced the risk of skin cancer by 14%, particularly among patients taking the treatment after a first skin cancer diagnosis. The benefits were more pronounced for squamous cell carcinoma, suggesting earlier intervention may be beneficial.
Researchers found that aging impairs CAR-T cell function and antitumor activity due to lower NAD levels. Rejuvenating aged cells with NAD-boosting compounds improves their effectiveness.
New research from the University of Copenhagen found that reducing skeletal muscle NAD+ levels in mice by 85% did not accelerate aging or impair whole-body metabolism. The study suggests that skeletal muscle can tolerate substantial NAD depletion without loss of function or accelerated aging.
Researchers developed a transformation process to boost H₂Sₙ yield from garlic-derived compounds, achieving significant H. pylori eradication outcomes. The use of chitosan-encapsulated microreactors demonstrated enhanced efficacy and faster eradication rates compared to conventional methods.
Researchers found significant discrepancies between actual and labelled amounts of Nicotinamide Mononucleotide (NMN) and Urolithin A (UA) in anti-ageing supplements. The discrepancies ranged from none to 28% more than stated amounts, highlighting a critical issue in the supplement industry.
A preliminary clinical trial found that nicotinamide riboside, a form of vitamin B3, increased the walking endurance of patients with peripheral artery disease by over 57 feet. The study suggests that nicotinamide riboside may be a new option for treating chronic leg disease.
A recent discovery reveals that the natural molecule trigonelline can increase NAD+ levels and improve muscle function during ageing. Lower levels of trigonelline were found in older people with sarcopenia, a condition where muscles weaken and mass is lost.
Indiana University researchers have found that nicotinamide nucleotide adenylyl transferase 2 (NMNAT2) plays a critical role in protecting the brain from aging and neurodegenerative diseases. The enzyme provides energy to axons, enabling them to carry out nerve impulses and maintain healthy function.
A recent study published in Nature Communications reveals that disrupted NAD(H) homeostasis is a key factor in tuberculosis pathogenesis. The researchers found that the glycolytic pathway can be selectively inhibited using an LDH enzyme with mostly LDHA subunits, which preferentially converts pyruvate to lactate and NADH to NAD+.
Researchers at Penn Medicine discovered that maintaining nicotinamide adenine dinucleotide (NAD) levels may protect against kidney disease. NAD supplements were shown to be effective in reversing NAD loss and suppressing inflammation in mouse kidneys, suggesting a potential therapeutic target for kidney disease prevention and treatment.
Researchers at The Hospital for Sick Children have discovered that dysregulation of energy production is an early sign of heart failure. They found that lysine demethylase 8 (Kdm8) helps maintain balanced energy use, but its suppression leads to changes in metabolism.
Nicotinamide riboside has been found to increase muscle mitochondria, improve gut bacterial composition, and boost NAD+ concentrations in humans. The findings suggest that NR supplementation may be a promising therapeutic option for diseases characterized by muscle mitochondrial dysfunction and/or gut microbiota imbalance.
A $1.1 million Department of Defense grant supports Augusta University research linking prostate cancer and cardiovascular diseases. Dr. Avirup Guha's research aims to investigate the aging process, exploring the role of nicotinamide adenine dinucleotide in this connection.
A study published in Cell Metabolism shows that nicotinamide riboside supplementation significantly increases NAD levels in the human brain and improves Parkinson's disease symptoms, suggesting a potential new treatment approach.
Researchers at Kanazawa University found that nicotinamide can activate plant immune systems, preventing or reducing fungal disease in wheat plants. The substance also increases the production of antimicrobial and antioxidant compounds.
A new study found that the anti-aging compound NMN improved insulin sensitivity in skeletal muscle of postmenopausal women with prediabetes. However, it did not lower blood glucose or blood pressure, and more research is needed to determine its clinical benefits.
Scientists discovered protein aggregates in skeletal muscles during natural aging, impairing mitochondrial function. However, boosting NAD+ levels with nicotinamide riboside and Olaparib restored mitochondrial homeostasis and reduced age-related proteotoxic aggregates in both worms and human muscle tissue.
A new study found that nicotinamide inhibits aggressive cell transformations and reverses the development of fibrous membranes in the retina, potentially treating fibrotic eye diseases. The compound also promotes the transition from mesenchymal to epithelial cells, helping to preserve their original identity.
A study at the University of Queensland found that a non-invasive treatment can maintain or restore egg quality and alleviate the biggest barrier to pregnancy for older women. The treatment uses a metabolic compound to boost energy levels in cells, which were found to be lower in older female mice.
A team of scientists has found that an analogue of vitamin B3, nicotinamide riboside, can increase the activity of hematopoietic stem cells and boost their ability to produce new blood cells. This breakthrough has significant implications for stem-cell therapy patients, particularly those undergoing chemotherapy or radiotherapy.
Researchers at WashU Medicine have identified a protein responsible for transporting nicotinamide mononucleotide (NMN) into cells, where it can be used to produce energy. This finding has implications for understanding the process of aging and developing therapies to boost cellular energy levels.
NAD+ supplementation improves cognitive function, reduces DNA damage and neuroinflammation in AD mouse model with DNA repair deficiency. Researchers report promising results with potential implications for Alzheimer's disease treatment.
Researchers found that supplementing cell cultures with nicotinamide riboside protects cells and prevents malignant transformation. The compound may be used in chemoprevention to prevent cancer development.
Researchers found that vitamin B3 nicotinamide can relieve preeclampsia symptoms, improve blood vessel damage, and even stimulate fetal growth in affected mothers. The treatment has shown promise as a potential alternative to delivery for pregnant women with the deadly disease.
Large doses of nicotinamide riboside have been found to effectively counteract the progress of Duchenne muscular dystrophy in animals, reducing muscle inflammation and increasing comfort. The treatment aims to provide worn-out mitochondria with fuel, reversing the disease's damaging effects.
Research shows that excess nicotinamide, a form of vitamin B3, causes overactivity of the TRPV ion channel, leading to cell death and behavioral changes in Caenorhabditis elegans. The study provides clues to the mechanism causing cell death and links it to behavior.
The first controlled clinical trial of nicotinamide riboside (NR) demonstrated that the compound is safe for humans and increases levels of a critical cell metabolite. NR supplementation has been shown to produce multiple health benefits, including improved control of blood sugar and cholesterol.
Nicotinamide significantly lowered the risk of common non-melanoma skin cancer in high-risk patients, reducing incidence by 23% compared to placebo controls. The treatment also cut the incidence of pre-cancerous sun spots by around 15%.
A new study suggests that nicotinamide, a form of vitamin B3, can increase the ability of immune cells to kill staph bacteria by 1,000 times. This could offer a new tool in the fight against 'superbugs' and potentially reduce dependence on antibiotics.
Research suggests that high nicotinamide intake can lead to reactive oxygen species production, insulin resistance, and glucose intolerance. Sweating is identified as an effective way to expel excess nicotinamide from the body, offering a potential preventive and therapeutic intervention for type 2 diabetes.
Researchers at UTSA have made a breakthrough discovery in the fight against tularemia, a deadly bio-warfare agent. They identified a unique metabolic pathway and enzyme, nicotinamide adenine dinucleotide synthetase (NMS), that is specific to Francisella tularensis, making it a potential target for therapeutic development.
A recent study found that nicotinamide, a water-soluble vitamin, lowered levels of phosphorylated tau protein, a key player in Alzheimer's disease development. The treatment also strengthened microtubules, the scaffolding within brain cells, helping to keep neurons alive and preventing symptoms in mice with Alzheimer's disease.
Researchers found that nicotinamide can protect against nerve damage in the chronic progressive phase of MS, preventing disability. Nicotinamide increased levels of NAD, which reduced neurologic deficits and protected axons from further degradation.
Researchers discovered that nicotinamide can protect mice from brain cell death and behavioral abnormalities caused by alcohol exposure. The study suggests that taking the drug soon after drinking alcohol may prevent some of the damage to the developing fetus.
Researchers identified nicotinamide riboside, a natural compound in milk, as a potential treatment for metabolic disorders and improved cancer therapy. The discovery may offer an alternative to existing treatments, such as niacin, which has uncomfortable side effects.
The PNC1 protein regulates nicotinamide, a form of vitamin B3, which acts as an inhibitor of Sir2, a founding member of proteins controlling cell survival and lifespan. This discovery suggests that lifespan is controlled by an active genetic program in cells, potentially boostable.